Recall Record

Olive Branch, MS, United States

Westminster Pharmaceuticals LLC recalls

3 recalls recorded since 2018, most recently on 6 August 2025. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)1
Terminated or completed2
Class I (FDA)1

Ongoing Class II Drugs

Recall started
6 August 2025
Reason
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0582-2025, D-0581-2025

Terminated Class II Drugs

Recall started
29 October 2018
Terminated
26 October 2021
Reason
CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in specific lots of Irbesartan.
Distribution
Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0300-2019, D-0302-2019, D-0301-2019

Terminated Class I Drugs

Recall started
3 August 2018
Terminated
3 June 2020
Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Distribution
Nationwide in the USA and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall numbers
D-1178-2018, D-1182-2018, D-1179-2018, D-1181-2018, D-1180-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.